Friday 6 November 2026
Export AMTX’s income statement to Excel — free account
Aemetis, Inc
AMTX Basic Materials Specialty Chemicals
Aemetis, Inc’s revenue for fiscal 2025 (year ended December 2025) was $197.6 million, down 26.2% from fiscal 2024.
- Revenue
- +48.9%
- EPS
- +118.9%
- Free cash flow
- +269.0%
- Total debt
- +12.6%
Quarter to September 2026, against a year earlier
1.62
0.11
−6.36%
Follow AMTX
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
7 | 5 | 4 | 4 |
+8 more TTM periods Free account |
| 10.08% | 19.68% | 24.65% | 26.98% | ||
| (11.28%) | (22.74%) | (28.93%) | (29.66%) | ||
ROIC |
19.40% | (17.17%) | (58.44%) | (74.29%) | |
Return on Tangible Assets |
22.38% | 43.21% | 53.44% | 61.76% | |
Average Days of Receivables |
0.00 | 24.05 | 11.48 | 11.01 | |
Free Cash Flow per Share |
(0.50) | (0.55) | (0.57) | (0.38) | |
Free Cash Flow |
(36.58) | (39.33) | (38.18) | (22.74) | |
Capital Expenditures |
(51.87) | (35.73) | (30.72) | (26.00) | |
| Other line items | |||||
Cash ROIC |
(57.07%) | (89.39%) | (96.56%) | (55.32%) | |
Accounts Receivable Turnover |
0.00 | 25.59 | 54.90 | 19.70 | |
Accounts Payable Turnover |
6.18 | 7.76 | 7.62 | 7.38 | |
Inventory Turnover |
23.23 | 15.86 | 12.77 | 11.26 | |
Average Days of Payables |
64.99 | 55.38 | 40.71 | 40.95 | |
Days of Inventory on Hand |
22.95 | 24.13 | 17.82 | 20.33 | |
Tax Rate |
(0.27) | 0.00 | (0.14) | (0.20) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
14.33% | 16.14% | 16.75% | 18.44% | |
Share Based Compensation of Revenue |
0.00% | 2.32% | 2.59% | 3.02% | |
Interest Coverage |
0.34 | (0.23) | (0.59) | (0.81) | |
Operating CF/Net income |
(0.49) | 0.06 | 0.10 | (0.04) | |
Depreciation/Fixed assets |
0.00 | 0.06 | 0.07 | 0.07 | |
Capex/Depreciation |
0.00 | (2.34) | (1.94) | (1.59) | |
Revenue per Share |
3.43 | 3.10 | 3.13 | 3.29 | |
Operating CF per Share |
0.21 | (0.05) | (0.11) | 0.05 | |
Capex per Share |
(0.72) | (0.50) | (0.46) | (0.43) | |
Capex to Sales |
0.21 | 0.16 | 0.15 | 0.13 |
Columns are period end dates · fundamentals updated 5 Nov 2026